Pregabalin, like other antiepileptic drugs, carries a warning for suicidal thoughts or behavior. New thoughts of self-harm require immediate safety assessment and provider notification. Dizziness, dry mouth, and somnolence are common adverse effects that still require teaching and monitoring, but improving mild symptoms are less urgent than a new suicide risk.
In-depth explanation
Clinical reasoning summary
New suicidal thoughts after pregabalin begins are an immediate safety priority. Assess intent and access to means, maintain safety, and notify the provider. Common dizziness or somnolence still warrants fall and driving precautions.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.